Format

Send to

Choose Destination
Trends Pharmacol Sci. 2013 May;34(5):290-8. doi: 10.1016/j.tips.2013.02.006. Epub 2013 Apr 1.

Molecular targeting of Gα and Gβγ subunits: a potential approach for cancer therapeutics.

Author information

1
Department of Pharmacology and Physiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. Alan_Smrcka@urmc.rochester.edu

Abstract

G-Protein-coupled receptors (GPCRs) signal through G protein α and βγ subunit families to regulate a wide range of physiological and pathophysiological processes. As such, GPCRs are major targets for therapeutic drugs. Downstream targets of GPCRs have also gained interest as a therapeutic approach to complex pathologies involving multiple GPCRs. One such approach involves targeting of the G proteins themselves. Several small molecule Gα and Gβγ modulators have been developed and been tested in various animal models of disease. Here we will discuss the requirements for targeting Gα and Gβγ subunits, the mechanisms of action of currently identified inhibitors, and focus on the potential utility of Gα and Gβγ inhibitors in the treatment of various cancers.

PMID:
23557963
PMCID:
PMC3924570
DOI:
10.1016/j.tips.2013.02.006
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center